Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Bristol Myers Squibb's Return on Invested Capital [ROIC] was 14.03% in Q3 2026, up 5.03 percentage points from 9.01% a year earlier but down 0.24 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2025, Return on Invested Capital [ROIC] at Bristol Myers Squibb came in at 10.88%, up 23.27 percentage points from FY2024.

  • Return on Invested Capital [ROIC] shows a five-year change of +18.23 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Invested Capital [ROIC] was -12.39% in FY2024 (-23.90 pp), 11.51% in FY2023 (+3.11 pp), 8.40% in FY2022 (+0.11 pp) and 8.29% in FY2021 (+15.64 pp).
  • Quarterly Return on Invested Capital [ROIC] has moved between -12.60% (Q4 2024) and 14.27% (Q2 2026) over five years.
  • Compared with a year earlier, Return on Invested Capital [ROIC] has increased for seven straight quarters, with an average year-over-year change of +8.25 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was Q4 2025 (a gain of 23.36 percentage points); the worst was Q4 2024 (a drop of 24.43 percentage points).
  • Per Business Quant data, BMY's Return on Invested Capital [ROIC] in the three quarters before Q3 2026 was 14.27% (Q2 2026), 11.35% (Q1 2026) and 10.76% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.57%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 24.28%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.52%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 22.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 15.60%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.11%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 12.34%
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 14.03%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.03%
Jun 30, 2026 14.27%
Mar 31, 2026 11.35%
Dec 31, 2025 10.76%
Sep 30, 2025 9.01%
Jun 30, 2025 7.57%
Mar 31, 2025 8.16%
Dec 31, 2024 -12.60%
Sep 30, 2024 -10.09%
Jun 30, 2024 -9.06%
Mar 31, 2024 -8.26%
Dec 31, 2023 11.83%
Sep 30, 2023 12.18%
Jun 30, 2023 11.44%
Mar 31, 2023 10.46%
Dec 31, 2022 8.92%
Sep 30, 2022 9.13%
Jun 30, 2022 8.77%
Mar 31, 2022 7.98%
Dec 31, 2021 8.63%
API Access

Bristol Myers Squibb Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=BMY&period=max&api_key=YOUR_API_KEY